nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.12	0.153	CbGbCtD
Halofantrine—CYP3A5—Dexamethasone—psoriatic arthritis	0.117	0.149	CbGbCtD
Halofantrine—CYP2C8—Dexamethasone—psoriatic arthritis	0.112	0.143	CbGbCtD
Halofantrine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0911	0.116	CbGbCtD
Halofantrine—CYP3A4—Betamethasone—psoriatic arthritis	0.0782	0.0996	CbGbCtD
Halofantrine—CYP3A4—Prednisolone—psoriatic arthritis	0.0771	0.0982	CbGbCtD
Halofantrine—CYP3A4—Prednisone—psoriatic arthritis	0.0728	0.0928	CbGbCtD
Halofantrine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0715	0.0911	CbGbCtD
Halofantrine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0455	0.0579	CbGbCtD
Halofantrine—Stomatitis—Auranofin—psoriatic arthritis	0.00516	0.024	CcSEcCtD
Halofantrine—Haematocrit decreased—Methotrexate—psoriatic arthritis	0.00492	0.0229	CcSEcCtD
Halofantrine—Visual impairment—Auranofin—psoriatic arthritis	0.00458	0.0213	CcSEcCtD
Halofantrine—Anorexia—Auranofin—psoriatic arthritis	0.00322	0.015	CcSEcCtD
Halofantrine—Dyspepsia—Auranofin—psoriatic arthritis	0.00297	0.0138	CcSEcCtD
Halofantrine—Decreased appetite—Auranofin—psoriatic arthritis	0.00293	0.0137	CcSEcCtD
Halofantrine—Constipation—Auranofin—psoriatic arthritis	0.00289	0.0134	CcSEcCtD
Halofantrine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00276	0.0129	CcSEcCtD
Halofantrine—Pulmonary oedema—Prednisolone—psoriatic arthritis	0.00269	0.0125	CcSEcCtD
Halofantrine—Urticaria—Auranofin—psoriatic arthritis	0.00268	0.0125	CcSEcCtD
Halofantrine—Abdominal pain—Auranofin—psoriatic arthritis	0.00267	0.0124	CcSEcCtD
Halofantrine—Pulmonary oedema—Triamcinolone—psoriatic arthritis	0.00247	0.0115	CcSEcCtD
Halofantrine—Pulmonary oedema—Methylprednisolone—psoriatic arthritis	0.00246	0.0115	CcSEcCtD
Halofantrine—Pruritus—Auranofin—psoriatic arthritis	0.00239	0.0111	CcSEcCtD
Halofantrine—Diarrhoea—Auranofin—psoriatic arthritis	0.00231	0.0108	CcSEcCtD
Halofantrine—Pulmonary oedema—Dexamethasone—psoriatic arthritis	0.00224	0.0104	CcSEcCtD
Halofantrine—Pulmonary oedema—Betamethasone—psoriatic arthritis	0.00224	0.0104	CcSEcCtD
Halofantrine—Vomiting—Auranofin—psoriatic arthritis	0.00215	0.00999	CcSEcCtD
Halofantrine—Rash—Auranofin—psoriatic arthritis	0.00213	0.00991	CcSEcCtD
Halofantrine—Dermatitis—Auranofin—psoriatic arthritis	0.00213	0.0099	CcSEcCtD
Halofantrine—Nausea—Auranofin—psoriatic arthritis	0.00201	0.00933	CcSEcCtD
Halofantrine—Pulmonary oedema—Prednisone—psoriatic arthritis	0.00195	0.00908	CcSEcCtD
Halofantrine—Abdominal distension—Prednisolone—psoriatic arthritis	0.00191	0.00887	CcSEcCtD
Halofantrine—Depressed level of consciousness—Methotrexate—psoriatic arthritis	0.00177	0.00824	CcSEcCtD
Halofantrine—Abdominal distension—Triamcinolone—psoriatic arthritis	0.00175	0.00816	CcSEcCtD
Halofantrine—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00175	0.00814	CcSEcCtD
Halofantrine—Pulmonary oedema—Methotrexate—psoriatic arthritis	0.00163	0.00759	CcSEcCtD
Halofantrine—Face oedema—Prednisone—psoriatic arthritis	0.00154	0.00715	CcSEcCtD
Halofantrine—Visual impairment—Prednisolone—psoriatic arthritis	0.00146	0.0068	CcSEcCtD
Halofantrine—Abdominal distension—Prednisone—psoriatic arthritis	0.00138	0.00645	CcSEcCtD
Halofantrine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00136	0.00632	CcSEcCtD
Halofantrine—Arrhythmia—Prednisolone—psoriatic arthritis	0.00135	0.0063	CcSEcCtD
Halofantrine—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00134	0.00624	CcSEcCtD
Halofantrine—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00124	0.00579	CcSEcCtD
Halofantrine—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00124	0.00578	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00122	0.0057	CcSEcCtD
Halofantrine—Visual impairment—Dexamethasone—psoriatic arthritis	0.00122	0.00567	CcSEcCtD
Halofantrine—Visual impairment—Betamethasone—psoriatic arthritis	0.00122	0.00567	CcSEcCtD
Halofantrine—Malaise—Prednisolone—psoriatic arthritis	0.00119	0.00554	CcSEcCtD
Halofantrine—Back pain—Triamcinolone—psoriatic arthritis	0.00117	0.00546	CcSEcCtD
Halofantrine—Convulsion—Prednisolone—psoriatic arthritis	0.00114	0.00532	CcSEcCtD
Halofantrine—Arrhythmia—Betamethasone—psoriatic arthritis	0.00113	0.00526	CcSEcCtD
Halofantrine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00113	0.00526	CcSEcCtD
Halofantrine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00113	0.00524	CcSEcCtD
Halofantrine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00112	0.00523	CcSEcCtD
Halofantrine—Discomfort—Prednisolone—psoriatic arthritis	0.00111	0.00516	CcSEcCtD
Halofantrine—Malaise—Triamcinolone—psoriatic arthritis	0.00109	0.00509	CcSEcCtD
Halofantrine—Malaise—Methylprednisolone—psoriatic arthritis	0.00109	0.00508	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00108	0.00501	CcSEcCtD
Halofantrine—Cough—Triamcinolone—psoriatic arthritis	0.00106	0.00493	CcSEcCtD
Halofantrine—Convulsion—Triamcinolone—psoriatic arthritis	0.00105	0.00489	CcSEcCtD
Halofantrine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00105	0.00488	CcSEcCtD
Halofantrine—Myalgia—Triamcinolone—psoriatic arthritis	0.00103	0.00481	CcSEcCtD
Halofantrine—Myalgia—Methylprednisolone—psoriatic arthritis	0.00103	0.0048	CcSEcCtD
Halofantrine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00103	0.0048	CcSEcCtD
Halofantrine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00102	0.00475	CcSEcCtD
Halofantrine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00102	0.00475	CcSEcCtD
Halofantrine—Discomfort—Triamcinolone—psoriatic arthritis	0.00102	0.00475	CcSEcCtD
Halofantrine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00102	0.00474	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—psoriatic arthritis	0.000999	0.00465	CcSEcCtD
Halofantrine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000996	0.00464	CcSEcCtD
Halofantrine—Malaise—Dexamethasone—psoriatic arthritis	0.000993	0.00462	CcSEcCtD
Halofantrine—Malaise—Betamethasone—psoriatic arthritis	0.000993	0.00462	CcSEcCtD
Halofantrine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00099	0.00461	CcSEcCtD
Halofantrine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000988	0.0046	CcSEcCtD
Halofantrine—Arrhythmia—Prednisone—psoriatic arthritis	0.000984	0.00458	CcSEcCtD
Halofantrine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000967	0.0045	CcSEcCtD
Halofantrine—Convulsion—Dexamethasone—psoriatic arthritis	0.000954	0.00444	CcSEcCtD
Halofantrine—Convulsion—Betamethasone—psoriatic arthritis	0.000954	0.00444	CcSEcCtD
Halofantrine—Myalgia—Betamethasone—psoriatic arthritis	0.000937	0.00436	CcSEcCtD
Halofantrine—Myalgia—Dexamethasone—psoriatic arthritis	0.000937	0.00436	CcSEcCtD
Halofantrine—Discomfort—Betamethasone—psoriatic arthritis	0.000926	0.00431	CcSEcCtD
Halofantrine—Discomfort—Dexamethasone—psoriatic arthritis	0.000926	0.00431	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000902	0.0042	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0009	0.00419	CcSEcCtD
Halofantrine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000898	0.00418	CcSEcCtD
Halofantrine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000898	0.00418	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000889	0.00414	CcSEcCtD
Halofantrine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000889	0.00414	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000887	0.00413	CcSEcCtD
Halofantrine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000887	0.00413	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—psoriatic arthritis	0.000887	0.00413	CcSEcCtD
Halofantrine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000871	0.00406	CcSEcCtD
Halofantrine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000869	0.00405	CcSEcCtD
Halofantrine—Malaise—Prednisone—psoriatic arthritis	0.000864	0.00402	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—psoriatic arthritis	0.000858	0.00399	CcSEcCtD
Halofantrine—Anorexia—Dexamethasone—psoriatic arthritis	0.000856	0.00399	CcSEcCtD
Halofantrine—Anorexia—Betamethasone—psoriatic arthritis	0.000856	0.00399	CcSEcCtD
Halofantrine—Urticaria—Prednisolone—psoriatic arthritis	0.000855	0.00398	CcSEcCtD
Halofantrine—Fatigue—Triamcinolone—psoriatic arthritis	0.000854	0.00397	CcSEcCtD
Halofantrine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000852	0.00396	CcSEcCtD
Halofantrine—Convulsion—Prednisone—psoriatic arthritis	0.00083	0.00387	CcSEcCtD
Halofantrine—Chills—Methotrexate—psoriatic arthritis	0.000826	0.00384	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000818	0.00381	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000818	0.00381	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—psoriatic arthritis	0.000816	0.0038	CcSEcCtD
Halofantrine—Myalgia—Prednisone—psoriatic arthritis	0.000816	0.0038	CcSEcCtD
Halofantrine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000816	0.0038	CcSEcCtD
Halofantrine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000814	0.00379	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000808	0.00376	CcSEcCtD
Halofantrine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000807	0.00375	CcSEcCtD
Halofantrine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000807	0.00375	CcSEcCtD
Halofantrine—Discomfort—Prednisone—psoriatic arthritis	0.000806	0.00375	CcSEcCtD
Halofantrine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000791	0.00368	CcSEcCtD
Halofantrine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000791	0.00368	CcSEcCtD
Halofantrine—Urticaria—Triamcinolone—psoriatic arthritis	0.000786	0.00366	CcSEcCtD
Halofantrine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000785	0.00365	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000782	0.00364	CcSEcCtD
Halofantrine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000781	0.00363	CcSEcCtD
Halofantrine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000781	0.00363	CcSEcCtD
Halofantrine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000781	0.00363	CcSEcCtD
Halofantrine—Back pain—Methotrexate—psoriatic arthritis	0.000775	0.00361	CcSEcCtD
Halofantrine—Fatigue—Betamethasone—psoriatic arthritis	0.000774	0.0036	CcSEcCtD
Halofantrine—Fatigue—Dexamethasone—psoriatic arthritis	0.000774	0.0036	CcSEcCtD
Halofantrine—Anorexia—Prednisone—psoriatic arthritis	0.000746	0.00347	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000743	0.00346	CcSEcCtD
Halofantrine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00074	0.00345	CcSEcCtD
Halofantrine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00074	0.00345	CcSEcCtD
Halofantrine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000735	0.00342	CcSEcCtD
Halofantrine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000735	0.00342	CcSEcCtD
Halofantrine—Malaise—Methotrexate—psoriatic arthritis	0.000722	0.00336	CcSEcCtD
Halofantrine—Urticaria—Dexamethasone—psoriatic arthritis	0.000714	0.00332	CcSEcCtD
Halofantrine—Urticaria—Betamethasone—psoriatic arthritis	0.000714	0.00332	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000713	0.00332	CcSEcCtD
Halofantrine—Dizziness—Prednisolone—psoriatic arthritis	0.000712	0.00331	CcSEcCtD
Halofantrine—Asthenia—Triamcinolone—psoriatic arthritis	0.00071	0.00331	CcSEcCtD
Halofantrine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00071	0.00331	CcSEcCtD
Halofantrine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00071	0.00331	CcSEcCtD
Halofantrine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000709	0.0033	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—psoriatic arthritis	0.000702	0.00327	CcSEcCtD
Halofantrine—Pruritus—Triamcinolone—psoriatic arthritis	0.0007	0.00326	CcSEcCtD
Halofantrine—Cough—Methotrexate—psoriatic arthritis	0.000699	0.00325	CcSEcCtD
Halofantrine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000699	0.00325	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—psoriatic arthritis	0.000694	0.00323	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—psoriatic arthritis	0.000689	0.00321	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—psoriatic arthritis	0.000682	0.00317	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—psoriatic arthritis	0.000682	0.00317	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—psoriatic arthritis	0.000682	0.00317	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—psoriatic arthritis	0.00068	0.00317	CcSEcCtD
Halofantrine—Rash—Prednisolone—psoriatic arthritis	0.000679	0.00316	CcSEcCtD
Halofantrine—Dermatitis—Prednisolone—psoriatic arthritis	0.000678	0.00316	CcSEcCtD
Halofantrine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000676	0.00315	CcSEcCtD
Halofantrine—Fatigue—Prednisone—psoriatic arthritis	0.000674	0.00314	CcSEcCtD
Halofantrine—Headache—Prednisolone—psoriatic arthritis	0.000674	0.00314	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—psoriatic arthritis	0.000674	0.00314	CcSEcCtD
Halofantrine—Constipation—Prednisone—psoriatic arthritis	0.000669	0.00311	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—psoriatic arthritis	0.000659	0.00307	CcSEcCtD
Halofantrine—Dizziness—Triamcinolone—psoriatic arthritis	0.000655	0.00305	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000654	0.00304	CcSEcCtD
Halofantrine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000653	0.00304	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000645	0.003	CcSEcCtD
Halofantrine—Asthenia—Betamethasone—psoriatic arthritis	0.000644	0.003	CcSEcCtD
Halofantrine—Asthenia—Dexamethasone—psoriatic arthritis	0.000644	0.003	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00064	0.00298	CcSEcCtD
Halofantrine—Nausea—Prednisolone—psoriatic arthritis	0.000639	0.00298	CcSEcCtD
Halofantrine—Pruritus—Betamethasone—psoriatic arthritis	0.000636	0.00296	CcSEcCtD
Halofantrine—Pruritus—Dexamethasone—psoriatic arthritis	0.000636	0.00296	CcSEcCtD
Halofantrine—Vomiting—Triamcinolone—psoriatic arthritis	0.000629	0.00293	CcSEcCtD
Halofantrine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000628	0.00292	CcSEcCtD
Halofantrine—Rash—Triamcinolone—psoriatic arthritis	0.000624	0.00291	CcSEcCtD
Halofantrine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000624	0.0029	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—psoriatic arthritis	0.000623	0.0029	CcSEcCtD
Halofantrine—Rash—Methylprednisolone—psoriatic arthritis	0.000623	0.0029	CcSEcCtD
Halofantrine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000622	0.0029	CcSEcCtD
Halofantrine—Urticaria—Prednisone—psoriatic arthritis	0.000621	0.00289	CcSEcCtD
Halofantrine—Headache—Triamcinolone—psoriatic arthritis	0.00062	0.00289	CcSEcCtD
Halofantrine—Headache—Methylprednisolone—psoriatic arthritis	0.000619	0.00288	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—psoriatic arthritis	0.000618	0.00288	CcSEcCtD
Halofantrine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000615	0.00286	CcSEcCtD
Halofantrine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000615	0.00286	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000596	0.00277	CcSEcCtD
Halofantrine—Dizziness—Dexamethasone—psoriatic arthritis	0.000594	0.00276	CcSEcCtD
Halofantrine—Dizziness—Betamethasone—psoriatic arthritis	0.000594	0.00276	CcSEcCtD
Halofantrine—Nausea—Triamcinolone—psoriatic arthritis	0.000588	0.00274	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000587	0.00273	CcSEcCtD
Halofantrine—Nausea—Methylprednisolone—psoriatic arthritis	0.000587	0.00273	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000575	0.00268	CcSEcCtD
Halofantrine—Vomiting—Betamethasone—psoriatic arthritis	0.000571	0.00266	CcSEcCtD
Halofantrine—Vomiting—Dexamethasone—psoriatic arthritis	0.000571	0.00266	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000568	0.00265	CcSEcCtD
Halofantrine—Rash—Dexamethasone—psoriatic arthritis	0.000566	0.00264	CcSEcCtD
Halofantrine—Rash—Betamethasone—psoriatic arthritis	0.000566	0.00264	CcSEcCtD
Halofantrine—Dermatitis—Betamethasone—psoriatic arthritis	0.000566	0.00263	CcSEcCtD
Halofantrine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000566	0.00263	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—psoriatic arthritis	0.000564	0.00262	CcSEcCtD
Halofantrine—Headache—Dexamethasone—psoriatic arthritis	0.000563	0.00262	CcSEcCtD
Halofantrine—Headache—Betamethasone—psoriatic arthritis	0.000563	0.00262	CcSEcCtD
Halofantrine—Asthenia—Prednisone—psoriatic arthritis	0.000561	0.00261	CcSEcCtD
Halofantrine—Pruritus—Prednisone—psoriatic arthritis	0.000553	0.00258	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000539	0.00251	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—psoriatic arthritis	0.000535	0.00249	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000535	0.00249	CcSEcCtD
Halofantrine—Nausea—Betamethasone—psoriatic arthritis	0.000534	0.00248	CcSEcCtD
Halofantrine—Nausea—Dexamethasone—psoriatic arthritis	0.000534	0.00248	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—psoriatic arthritis	0.000519	0.00242	CcSEcCtD
Halofantrine—Dizziness—Prednisone—psoriatic arthritis	0.000517	0.00241	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000517	0.00241	CcSEcCtD
Halofantrine—Vomiting—Prednisone—psoriatic arthritis	0.000497	0.00232	CcSEcCtD
Halofantrine—Rash—Prednisone—psoriatic arthritis	0.000493	0.0023	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—psoriatic arthritis	0.000493	0.00229	CcSEcCtD
Halofantrine—Headache—Prednisone—psoriatic arthritis	0.00049	0.00228	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—psoriatic arthritis	0.000469	0.00218	CcSEcCtD
Halofantrine—Nausea—Prednisone—psoriatic arthritis	0.000465	0.00216	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—psoriatic arthritis	0.000463	0.00215	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000447	0.00208	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—psoriatic arthritis	0.000432	0.00201	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—psoriatic arthritis	0.000416	0.00193	CcSEcCtD
Halofantrine—Rash—Methotrexate—psoriatic arthritis	0.000412	0.00192	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—psoriatic arthritis	0.000412	0.00192	CcSEcCtD
Halofantrine—Headache—Methotrexate—psoriatic arthritis	0.00041	0.00191	CcSEcCtD
Halofantrine—Nausea—Methotrexate—psoriatic arthritis	0.000388	0.00181	CcSEcCtD
